Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples